FIND A DERM    

MIRVASO

Rosacea Redness

Savings & Support

MIRVASO Savings & Support

Save on MIRVASO and get a skin care guide and discussion starters for talking with your doctor

With the MIRVASO® (brimonidine) topical gel, 0.33%* Cost Reduction Card, patients with certain insurance may pay no more than $50 and patients whose insurance does not cover MIRVASO may pay no more than $80 for a tube of MIRVASO. The MIRVASO Cost Reduction Card is good for refills, so use your card each time you refill your MIRVASO prescription.

Select the items you wish to receive. *REQUIRED

MIRVASO Cost Reduction Card (Restrictions may apply. See PROGRAM INFORMATION for details.)
Preparing for Your Appointment
Skin Care & Triggers Guide
*I would like to receive information from Galderma about MIRVASO & other rosacea products
YES
NO
*How would you like to receive your requested materials?
BY EMAIL
DOWNLOAD NOW
Galderma will not sell your information, and you will not receive anything from us that you have not agreed to receive. For more information, please read our PRIVACY POLICY.
*I'm 18 years or older
YES
NO
Wait! Don’t forget your savings card. The MIRVASO Cost Reduction Card may help you save on your prescription.
Loading ...  

Important Safety Information
Indication:  Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.  Adverse Events:  In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis.  Warnings/Precautions:  Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.

Offer not available for uninsured or cash patients. $50 offer is only available to insured patients with coverage for MIRVASO. Insured patients without coverage for MIRVASO may pay no more than $80 for each prescription. Offer excludes Medicaid, Medicare, and federal or state healthcare programs. Maximum benefit to eligible patients does not exceed $200. Certain limitations may apply. See PROGRAM INFORMATION for details.

MIRVASO Cost Reduction Card Program Information

1. Offer not available for uninsured or cash patients.  2. $50 offer is only available to insured patients with coverage for Mirvaso® Gel.  3. Insured patients without coverage for Mirvaso® Gel may pay no more than $80 for each prescription.  4. Maximum benefit to eligible patients does not exceed $200.  5. This offer is not valid if prescriptions are paid by any state or other federally funded programs, including, but not limited to Medicare or Medicaid, Medigap, VA, DOD or TRICARE®.  6. This card is good for use only with a Mirvaso® Gel prescription at the time the prescription is filled by the pharmacist and dispensed to the patient.  7. Offer good only in the USA at participating retail pharmacies and cannot be redeemed at government-subsidized clinics.  8. Galderma Laboratories, L.P. reserves the right to rescind, revoke, or amend this offer without notice at any time.  9. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.  10. Cash value is 1/100th of 1¢.  11. By using this card, you demonstrate that you understand and agree to comply with the terms and conditions of this offer as set forth on this card.  12. Actual payment for product will depend on individual insurance coverage.

1 of 4
Yes No
2 of 4
Yes No
3 of 4
Yes No
4 of 4
Yes No


You answered yes to questions.

Your facial redness could be related to rosacea.
To know for sure, visit your doctor and discuss your symptoms.


Your answers don't provide enough information to tell you if you could have the
facial redness of rosacea. Talk to your doctor about your symptoms.

Find a Dermatologist:
Next


Important Safety Information
Indication:  Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.  Adverse Events:  In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis.  Warnings/Precautions:  Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Continue to mirvaso.com